日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment

使用索尼德吉和维莫德吉治疗基底细胞癌患者的真实世界治疗模式：停药率和治疗期间的临床状况

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01621-w
Lebwohl, Mark G; Rigel, Darrell S; Eroglu, Zeynep; Barghout, Victoria E; Gupta, Deepshekhar; Zanardo, Enrico; Huynh, Lynn; Yenikomshian, Mihran A; Squittieri, Nicholas; Ferro, Thomas J; Patel, Kunal
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Reduction in Facial Sebum Production Following Treatment with Clascoterone Cream 1% in Patients with Acne Vulgaris: 12-Week Interim Analysis

使用1%克拉斯科酮乳膏治疗寻常痤疮患者后面部皮脂分泌减少：12周中期分析

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01495-y
Draelos, Zoe D; Kyeremateng, Kizito; Squittieri, Nicholas
发表日期：2025
文献求助 收藏

Clascoterone Stability When Combined with Topical Acne Medications In Vitro

体外实验中，克拉司酮与局部痤疮药物联合使用时的稳定性

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01553-5
Draelos, Zoe D; Draelos, Matthew M; Kyeremateng, Kizito; Squittieri, Nicholas
发表日期：2025
文献求助 收藏

Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early-Phase Clinical Study Participants

克拉司酮乳膏在早期临床研究参与者中的药代动力学、安全性、皮肤刺激性和致敏性

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.1561
Di Stefano, Andrea Francesco Daniele; Radicioni, Milko Massimiliano; Garhöfer, Gerhard; Cartwright, Martina; Müller, Markus; Kopeloff, Iris; Moro, Luigi; Squittieri, Nicholas; Mazzetti, Alessandro
发表日期：2025
文献求助 收藏

Production of Antioxidant Transfersomes by a Supercritical CO(2) Assisted Process for Transdermal Delivery Applications

利用超临界CO₂辅助工艺制备抗氧化转移体用于透皮给药

期刊:Nanomaterials
影响因子:4.3
doi:10.3390/nano13121812
Squittieri, Raffaella; Baldino, Lucia; Reverchon, Ernesto
发表日期：2023
文献求助 收藏

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

索尼德吉改善了晚期基底细胞癌患者的生活质量：LDE225治疗基底细胞癌的II期临床试验73周结果

期刊:
影响因子:
doi:10.1016/j.jdin.2022.08.027
Migden, Michael; Loquai, Carmen; Robert, Caroline; Baurain, Jean-François; Squittieri, Nicholas; Arntz, Ramon; Dierlamm, Jörg; Dréno, Brigitte
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis

接受索尼德吉或维莫德吉治疗的晚期基底细胞癌患者的主要临床不良事件：一项事后分析

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-021-00588-8
Gutzmer, Ralf; Loquai, Carmen; Robert, Caroline; Dréno, Brigitte; Guminski, Alexander; Lewis, Karl; Arntz, Ramon; Martelli, Serena; Squittieri, Nicholas; Kheterpal, Meenal
肿瘤免疫
细胞生物学
肿瘤
发表日期：2021
文献求助 收藏

Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial

在为期 42 个月的 BOLT 试验中，晚期基底细胞癌患者在剂量减少和治疗中断后索尼德吉的疗效

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-021-00619-4
Lewis, Karl; Dummer, Reinhard; Farberg, Aaron S; Guminski, Alexander; Squittieri, Nicholas; Migden, Michael
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Evaluation of the Octreotide Acetate Pen Injector and its Instructions for Use in a Formative Human Factors Study

在一项初步的人体因素研究中对奥曲肽醋酸盐注射笔及其使用说明进行评估

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-01739-1
Andre, Anthony; Squittieri, Nicholas; Patil, Satyashodhan B
Human
发表日期：2021
文献求助 收藏

Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis

采用 ERIVANCE 样标准评估接受索尼德吉治疗的局部晚期基底细胞癌患者的各种疗效结果：一项预先计划的敏感性分析的结果

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-021-08968-1
Gutzmer, Ralf; Robert, Caroline; Loquai, Carmen; Schadendorf, Dirk; Squittieri, Nicholas; Arntz, Ramon; Martelli, Serena; Dummer, Reinhard
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏